Atlas Genetics
Manufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
245 1st St, Cambridge, Massachusetts, 02...Phone Number
+44 1225717930Website
www.atlasgenetics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Atlas Genetics
binx health is focused on transforming healthcare through point-of-care molecular diagnostics, aiming to enhance convenient and equitable access to healthcare. Their flagship product, binx io, is a molecular testing platform that allows for rapid diagnosis and treatment of chlamydia and gonorrhea infections within a single visit. The company partners with various healthcare providers to break down traditional barriers to care and improve patient experiences. Their intended clients include healthcare facilities and organizations looking to expand their diagnostic capabilities and improve sexual health services.Explore more
Atlas Genetics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Atlas Genetics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Atlas Genetics recently announced quarterly report
Funding: Get notified immidiatlly once Atlas Genetics has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Atlas Genetics, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Atlas Genetics is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Atlas Genetics
Click to see if Atlas Genetics had a recent Job posting/layoffs
Check if Atlas Genetics has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Atlas Genetics launches new products
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Atlas Genetics
Find 3 more new buyers
Company Profile Activity
Activity Insights
Atlas Genetics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Atlas Genetics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Atlas Genetics.
Atlas Genetics financials insights
Gather financial insights about Atlas Genetics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2007
Series A
$2.5M
2014
Series B
$28.4M
2015
Series C
$20M
2017
Series D
$35M
Atlas Genetics Tech Stack
A closer look at the technologies used by Atlas Genetics
See more technologies
Atlas Genetics News & Media
Publication Demonstrates Important Healthcare Benefits of Point-of-Care Testing for Sexually Transmitted Infections
BATH, England and CAMBRIDGE, Mass., Sept. 26, 2018 /PRNewswire/ -- A recent study published in BMJ Open shows that a 30-minute combined test for chlamydia and gonorrhoea could provide important cost and health benefits to patients compared to standard of care, microscopy plus a laboratory ...Life Sciences Pioneer Stanley Lapidus Joins Atlas Genetics Board of Directors
CAMBRIDGE, Mass. & BATH, England--(BUSINESS WIRE)--Atlas Genetics, a rapid, near-patient and point-of-care (POC) testing company, today announced that it has appointed Stanley Lapidus to the role of independent board member on its Board of Directors. Lapidus has more than 30 years’ experience in the medical diagnostics industry as a founder, CEO and board member at companies that have dramatically impacted the diagnostics landscape, including his founding of EXACT Sciences Corp. (NASDAQ:EXAS) aVC-backed Atlas Genetics appoints Jones as COO and CFO
UK-based Atlas Genetics, a near patient and point-of-care testing company, has named Marc Jones as chief operating officer and chief financial officer. Previously, Jones worked at Good Start Genetics, where he served as COO and CFO. Atlas Genetics is backed by Novartis Venture Fund, Consort Medical, Wondfo Biotech, LSP Venture Capital, BB Biotech, Johnson & Johnson Innovation, RMI Investments and Southwest Ventures Fund.Atlas Genetics Expands Executive Team, Appointing Marc Jones as Chief Operating Officer and Chief Financial Officer
CAMBRIDGE, Mass. & BATH, United Kingdom--(BUSINESS WIRE)--Atlas Genetics, a rapid, near-patient and point-of-care (POC) testing company, today announced the appointment of industry veteran Marc Jones as Chief Operating Officer (“COO”) and Chief Financial Officer (“CFO”). In this dual role, Jones will lead Atlas Genetics’ finance and operations functions, as well as new channel development, and he will again partner with Jeffrey Luber, President and Chief Executive Officer of Atlas, in key areas
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Atlas Genetics
Sign Up For FreeTo access detailed company insights
binx health is focused on transforming healthcare through point-of-care molecular diagnostics, aiming to enhance convenient and equitable access to healthcare. Their flagship product, binx io, is a molecular testing platform that allows for rapid diagnosis and treatment of chlamydia and gonorrhea infections within a single visit. The company partne... Read More
